
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Are you Dr. Curry?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Curry, MD is a board certified pathologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Illinois, and Illinois.
Education & Training
- Loyola University Medical CenterResidency, Pathology-Anatomic and Clinical, 1998 - 2003
- Loyola University Chicago Stritch School of MedicineClass of 1998
- Loyola University Chicago Stritch School of MedicineClass of 1998
Certifications & Licensure
- TX State Medical License 2004 - 2026
- IL State Medical License 1998 - 2014
- IL State Medical License 1998 - 2014
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes.Erol Can Bayraktar, Phyu P Aung, Pavandeep Gill, Guomiao Shen, Varshini Vasudevaraja
Journal of Cutaneous Pathology. 2025-04-01 - 1 citationsBCR::ZNF711 and BCR::CYLC2 Fusions: Novel BCR Fusions Expanding the Molecular Spectrum of Gene Fusions in Melanoma.Elsayed Ibrahim, Richard K Yang, Jonathan L Curry, Woo Cheal Cho
The American Journal of Dermatopathology. 2024-11-01 - Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma.Debora A Ledesma, Mario L Marques-Piubelli, Elsa Li-Ning-Tapia, Courtney Hudgens, Jun Gu
The American Journal of Dermatopathology. 2024-07-01
Press Mentions
- Is Immunohistochemical Expression of GATA3 Helpful in the Differential Diagnosis of Transformed Mycosis Fungoides and Primary Cutaneous CD30-Positive T Cell Lymphoproliferative Disorders?February 18th, 2021
- Cover ImageAugust 16th, 2019